EXCLUSIVE RIGHT TO LICENSE AGREEMENTExclusive Right to License Agreement • April 4th, 2008 • Edgeline Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledApril 4th, 2008 Company IndustryOncolin Therapeutics, Inc. of Houston, Texas would like to evaluate Genistein analogs and the Pharmaceutical Research Institute ( PRI ) and Dr. Janusz Obukowicz would like to have the same analogs evaluated and therefore agree to the following terms: